Chemours Company (the) · NYSE:CC
Chemours Company (the) — The Chemours Company — Merger or Acquisition (April 2015)
17 slides from Chemours Company (the)'s merger presentation, Apr 21, 2015
Slide 1: Chemours Form 10 Highlights
CHEMOURS FORM 10 HIGHLIGHTS April 21, 2015
Slide 2: Forward Looking Statements
Forward Looking Statements This document contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates,” “anticipates” or other words of similar meaning. All statements that address expectations or projections abo
Slide 3: Performance Chemicals Separation Background
Performance Chemicals Separation Background DUPONT THE CHEMOURS COMPANY • Leading technologies • Leading businesses • Science leverage across businesses • Customer focused applications development • Customer focused applications development • Low cost production • Targets secular driven growth • Cap
Slide 4: Performance Chemicals Separation Timeline
Performance Chemicals Separation Timeline Form 10 Amendments - Pro forma financial statements Initial Form 10 - Capital Structure Debt Road Equity Road and Dividend Filing Show Show Policy Expected Spin December January–June 2015 Early 2nd Quarter June July 2014 2015 2015 2015 On Track to Expected C
Slide 5: Update
Update 5
Slide 6: The Chemours Company at a Glance
The Chemours Company at a Glance Overview 2014 Sales by Segment • Leading global provider of performance chemicals Chemical Solutions • Reporting segments include Titanium 18% Fluoroproducts Technologies, Fluoroproducts, and Chemical 36% Solutions • Approximately 9,100 employees Titanium • 37 produc
Slide 7: Titanium Technologies Segment Overview
Titanium Technologies Segment Overview The leading global producer of titanium dioxide (“TiO2”), a premium white pigment used to deliver opacity Key Information 2014 Sales $2.9B 2014 Adjusted EBITDA* $759 Million Key Products Ti02 Key Applications Coatings, Plastics, Laminates, Paper Products Compet
Slide 8: Fluoroproducts Segment Overview
Fluoroproducts Segment Overview A leading global provider of fluoroproducts, such as refrigerants and industrial fluoropolymer resins Key Information 2014 Sales $2.3B 2014 Adjusted EBITDA* $330 Million Krytox® Performance Lubricants, Teflon® PTFE Resins, Key Products Formacel® Foam Expansion Agents,
Slide 9: Chemical Solutions Segment Overview
Chemical Solutions Segment Overview A leading North American provider of industrial and specialty performance chemicals used in gold production, oil refining, agriculture, industrial polymers and other industries Key Information 2014 Sales $1.2B 2014 Adjusted EBITDA* $29 Million Key Products Aniline
Slide 10: Form 10 – Amendment No. 2
As fled with the U-S. Securities and Exchange Commission on (April 21), 2015 j UNITED STATES SECURITIES AND EXCHANGE COMMISSION ‘Washington, D.C. 20549 { 1007 Market Street, Wilmington, Delaware 19898 (dares of principal executive offices) ip Code) j ‘Registrant's telephone number, including area co
Slide 11: The Chemours Company – What's Changed
The Chemours Company – What’s Changed Approximately $4B in Debt Issuance • Combination term loans, and senior unsecured notes • Weighted average estimated interest rate of 5.75% • Focused on maintaining BB ratings profile • Expect to have an available Revolving Credit Facility that is undrawn Chemou
Slide 12: The Chemours Company – Balance Sheet
The Chemours Company – Balance Sheet* 12/31/2014 Total Assets $6.0B Key Components: Accounts & notes receivable – trade, net $0.8 Inventories and other current assets $1.2 Net property, plant & equipment $3.3 Non-current assets $0.7 Total Liabilities $2.3B Key Components: Accounts payable $1.0 Other
Slide 13: The Chemours Company – 2014 Segment Results
The Chemours Company – 2014 Segment Results Compared to 2014 DuPont Performance Chemicals ($ Millions) ( $170) $257 ($105) $913 $638 $895 Perf Chem Chemours Chemours PTOI (DuPont)* Adjusted EBIT** Adjusted EBITDA** DuPont 10-K Chemours Form 10 Chemours Form 10 Including Viton® 2014 Corporate Legal,
Slide 14: The Chemours Company – Statement of Cash Flows
The Chemours Company – Statement of Cash Flows Statement of Cash Flows ($MM) 2014 Cash Flow Commentary Cash Provided by Operating Activities 2012 2013 2014 • Cash provided by operating activities for 2014 declined by $293 million due to: Cash • A litigation settlement payment of Provided by $1,390 $
Slide 15: Appendix
Appendix 15
Slide 16: The Chemours Company – 2014 Segment Profitability
The Chemours Company – 2014 Segment Profitability $MM Titanium Chemical Corporate and Fluoroproducts Total Technologies Solutions Other Net Sales $2,937 $2,327 $1,168 - $6,432 Adjusted EBITDA 759 330 29 (223) 895 Depreciation and 125 83 48 1 257 Amortization Adjusted EBIT $638 Non-operating pension
Slide 17: Copyright and trademark notice
Copyright©©2014 Copyright 2015DuPont DuPontororitsits affiliates. affiliates. All All rights rights reserved. reserved. The DuPont DuPontOvalOvalLogo, Logo,DuPont™, DuPont™, The Themiracles miracles of science™ of science™ and all and all products productsdenoted denoted with with™™ or or ® are ® ar
The Chemours Company — Merger or Acquisition (April 2015) on 6ix